Why Is Apomorphine So Hard to Find? [Explained for 2026]

If you or a loved one relies on apomorphine to manage Parkinson's disease, you know how frustrating it can be to find it at a pharmacy. Unlike common medications you can pick up at any drugstore, apomorphine is a specialty drug with special handling, storage, and dispensing requirements that make it far less accessible. This guide explains exactly why apomorphine is difficult to find—and what steps you can take to secure your supply in 2026.

What Is Apomorphine and Why Does It Matter?

Apomorphine is a non-ergoline dopamine agonist used to treat acute "off" episodes in people with advanced Parkinson's disease. "Off" episodes are periods when Parkinson's symptoms—tremor, rigidity, and slow movement—return as levodopa or other medications wear off. Apomorphine works quickly to restore mobility, often within 20 minutes of a subcutaneous injection.

Currently, apomorphine is available in two main forms in the United States: Apokyn (an injectable pen) and Onapgo (a wearable continuous infusion device approved by the FDA in February 2025). The fact that there are now multiple delivery systems—each with its own specialty pharmacy requirements—adds another layer of complexity for patients trying to fill their prescriptions.

Why Is Apomorphine Only Available at Specialty Pharmacies?

The number one reason apomorphine is difficult to find is that it is a specialty medication, which means it cannot be dispensed at most retail pharmacies. Specialty pharmacies are required to handle, store, and ship these drugs according to strict standards set by manufacturers and regulators. Not every Walgreens, CVS, or independent pharmacy carries specialty drugs like apomorphine.

Additionally, your insurance plan may have a preferred specialty pharmacy network, meaning you can only fill apomorphine at specific locations. If your plan's preferred specialty pharmacy does not have the drug in stock, you may face significant delays getting your prescription filled.

Is There an Apomorphine Shortage in the US in 2026?

As of 2026, the FDA has not issued a formal drug shortage notice for apomorphine in the US market. However, supply chain tightness at the specialty pharmacy level is a separate issue from an FDA-declared shortage. In the UK, APO-go prefilled syringes were discontinued in September 2025, which has created localized supply pressures in that region. US patients using Apokyn or Onapgo have faced inventory limitations at individual specialty pharmacies, particularly when demand surges after a major news event or formulary change.

The 2025 launch of Onapgo—the first wearable continuous infusion device for apomorphine in the US—added additional demand pressure to the specialty pharmacy supply chain. Because Onapgo is a brand-new product, fewer pharmacies stock it, and the hub support infrastructure is still maturing.

Why Does Apomorphine Require Such Complex Pharmacy Handling?

Several clinical requirements make apomorphine more complicated to dispense than a typical oral medication:

First-dose supervision required: The FDA requires that the first dose of apomorphine be administered in a medical setting where the patient can be monitored. This is not a drug you can simply pick up and start using at home.

Antiemetic pre-treatment required: Patients must begin trimethobenzamide (an anti-nausea drug) three days before starting apomorphine. This adds a coordination step between the prescriber and pharmacist.

Injection form only: Apomorphine must be given subcutaneously (under the skin). It cannot be taken orally because the liver destroys it before it can reach the brain. This limits which pharmacies are equipped to educate patients and fill the prescription.

Dangerous drug interactions: Apomorphine is contraindicated with a class of common anti-nausea medications called 5-HT3 antagonists (including ondansetron/Zofran), which can cause profound hypotension and loss of consciousness. Pharmacies must verify patients are not on these drugs before dispensing.

Why Does Insurance Make It Even Harder to Get?

Even if you find a specialty pharmacy that carries apomorphine, insurance hurdles can delay access by days or even weeks. Here's what typically stands in the way:

Prior authorization (PA): Most commercial and Medicare plans require PA before covering apomorphine. Your neurologist must submit documentation proving the medical necessity.

Step therapy: Some plans require patients to try and fail cheaper Parkinson's drugs—such as oral dopamine agonists—before they'll approve apomorphine.

High specialty tier copays: Even with insurance, specialty drug copays can run hundreds or thousands of dollars per month until a deductible is met.

The Cost Factor: Why Availability and Affordability Both Matter

The retail cash price for apomorphine is strikingly high. The brand-name Apokyn can retail for over $7,000 for a 15 mL supply, and the new Onapgo infusion system can cost upward of $8,500–$9,500 for a monthly supply. Even with GoodRx or SingleCare coupons applied to generic apomorphine injection, patients may still pay $315–$1,800 per cartridge.

This high cost means that some patients delay refilling or ration doses—effectively creating their own supply crisis separate from any pharmacy shortage. Supernus Pharmaceuticals offers a patient support program (reach them at 877-727-6596) for patients who need financial assistance.

What Can You Do When Your Pharmacy Doesn't Have Apomorphine?

When your specialty pharmacy is out of stock, here are concrete steps to take:

Contact your neurologist immediately. Do not wait. Your doctor's office may have relationships with multiple specialty pharmacies and can help locate stock faster.

Call other specialty pharmacies in your area or region. Large specialty pharmacies like Walgreens Specialty, CVS Specialty, and Accredo often have separate stock from their retail counterparts.

Use medfinder. medfinder calls pharmacies near you to check which ones can fill your apomorphine prescription—so you don't have to spend hours on hold yourself. Visit medfinder.com to get started.

Ask about emergency supply. Some specialty pharmacies can provide a short bridge supply while the full order is being processed.

Will Apomorphine Get Easier to Find in the Future?

There is reason for optimism. The FDA approval of Onapgo in February 2025 increased market attention on apomorphine and the Parkinson's disease treatment pipeline. As Supernus Pharmaceuticals expands its specialty pharmacy network and more pharmacists become trained in apomorphine dispensing, access should gradually improve.

In the meantime, patients and caregivers need practical tools to locate stock quickly. Check out our guide to how to find apomorphine in stock near you for step-by-step tips.

You can also read our related post on alternatives to apomorphine if you can't fill your prescription to learn about backup options to discuss with your neurologist.